2022
DOI: 10.1038/s41409-022-01883-4
|View full text |Cite
|
Sign up to set email alerts
|

Second allogeneic hematopoietic stem cell transplantation in patients with inborn errors of immunity

Abstract: Graft failure (GF) remains a serious issue of hematopoietic stem cell transplantation (HSCT) in inborn errors of immunity (IEI). Second HSCT is the only salvage therapy for GF. There are no uniform strategies for the second HSCTs and limited data are available on the second HSCT outcomes. 48 patients with various IEI received second allogeneic HSCT from 2013 to 2020. Different conditioning regimens were used, divided into two main groups: containing myeloablative doses of busulfan/treosulfan (n = 19) and lymph… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…Of note, the number of second HSCT procedures in Russia remains consistent (about 13% of all HSCTs). This corresponds to a rejection rate in IEI patients reported for IEI by one of the participating centers [ 34 ].…”
Section: Discussionmentioning
confidence: 99%
“…Of note, the number of second HSCT procedures in Russia remains consistent (about 13% of all HSCTs). This corresponds to a rejection rate in IEI patients reported for IEI by one of the participating centers [ 34 ].…”
Section: Discussionmentioning
confidence: 99%
“…Incidence of chronic GvHD was 9%. The 5-year OS was 73% [85]. center Study of JAK1/2 inhibitor Ruxolitinib added to corticosteroids in pediatric patients with treatment-Naïve or Steroid-Refractory acute GvHD.…”
Section: Non-malignant Disordersmentioning
confidence: 98%